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Abstract
Background: The objective of this study is to conduct a systematic review of studies reporting the frequency of
neurocysticercosis (NCC) worldwide.
Methods/Principal Findings: PubMed, Commonwealth Agricultural Bureau (CAB) abstracts and 23 international databases
were systematically searched for articles published from January 1, 1990 to June 1, 2008. Articles were evaluated for
inclusion by at least two researchers focusing on study design and methods. Data were extracted independently using
standardized forms. A random-effects binomial model was used to estimate the proportion of NCC among people with
epilepsy (PWE). Overall, 565 articles were retrieved and 290 (51%) selected for further analysis. After a second analytic phase,
only 4.5% of articles, all of which used neuroimaging for the diagnosis of NCC, were reviewed. Only two studies, both from
the US, estimated an incidence rate of NCC using hospital discharge data. The prevalence of NCC in a random sample of
village residents was reported from one study where 9.1% of the population harboured brain lesions of NCC. The proportion
of NCC among different study populations varied widely. However, the proportion of NCC in PWE was a lot more consistent.
The pooled estimate for this population was 29.0% (95%CI: 22.9%–35.5%). These results were not sensitive to the inclusion
or exclusion of any particular study.
Conclusion/Significance: Only one study has estimated the prevalence of NCC in a random sample of all residents. Hence,
the prevalence of NCC worldwide remains unknown. However, the pooled estimate for the proportion of NCC among PWE
was very robust and could be used, in conjunction with estimates of the prevalence and incidence of epilepsy, to estimate
this component of the burden of NCC in endemic areas. The previously recommended guidelines for the diagnostic process
and for declaring NCC an international reportable disease would improve the knowledge on the global frequency of NCC.
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Introduction
Scientific evidence is instrumental to improving global public
health, as health policies should be based on accurate and
meaningful data. In early 1990, the first Global Burden of Diseases
(GBD) study, commissioned by the World Bank, was launched to
develop a method to estimate and compare the burden of 107
diseases and injuries around the world. A standardized indicator,
the ‘‘Disability Adjusted Life Years’’ (DALY) method, was
developed for this purpose [1–2]. Unfortunately, only a few
neglected tropical diseases (NTD) and no neglected tropical
zoonoses were taken into account in the original GBD study.
Neglected tropical diseases are a public health issue worldwide
and especially in developing countries, where risk factors for their
transmission are common [3]. These conditions tend to affect the
poorest of the poor, which has led to limited research interest and
investments for these infections. The few research initiatives that
have been undertaken to estimate the burden of NTDs have been
criticized for grossly underestimating their global impact [4–6]. In
addition, the burden of several zoonotic NTDs, such as Taenia
solium cysticercosis, has never been estimated.
The lifecycle of T. solium is illustrated in Figure 1. Humans
acquire cysticercosis when ingesting food that has been contam-
inated with infected feces or through auto-infection. Neurocysti-
cercosis (NCC), which occurs when the larvae of T. solium migrate
to the brain, has been reported as the most frequent helminthic
infection of the central nervous system (CNS) [5,7]. Yet, there
have been very few studies conducted to estimate the prevalence of
NCC. This is mostly due to the fact that NCC can only be
diagnosed with certainty through neuro-imaging or autopsy.
Hence, the frequency of sequelae following infection with the
larval stages of T. solium remains largely unknown [8]. Exact data
on the worldwide frequency of CNS infections with cysticercosis is
lacking [9].
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The primary objective of this study was to conduct a systematic
review of the literature to gather data on estimates of NCC
frequency between 1990 and 2008 by age group and region. A
secondary aim was to estimate the proportion of people living with
epilepsy (PWE) who have NCC. This study was commissioned by
the World Health Organization’s Foodborne Disease Burden
Epidemiology Reference Group (FERG). The FERG is the World
Health Organization’s advisory body to estimate the global burden
of foodborne diseases.
Methods
A systematic search of the literature was conducted to gather
valid information on the frequency (prevalence proportion,
incidence rate, or proportion among a specific population) of
NCC between 1990 and 2008.
Searching
The search strategy was conducted in three phases. In phase I,
PubMed, Commonwealth Agricultural Bureau (CAB) Abstracts,
and 23 international databases (Table 1) were screened for articles
published from January 1, 1990 to June 1, 2008. Searches were
restricted to languages that at least two of the members of the team
could read and understand, namely English, French, Italian,
Romanian, German, Chinese, Spanish and Portuguese. In
PubMed, our search strategy included the Medical Search
Heading (MeSH) terms: ‘‘Neurocysticercosis/epidemiology’’. Be-
cause CAB Abstracts and the international search engines did not
allow for searches using MeSH terms, they were queried using the
following keywords: ‘‘Taenia solium’’, ‘‘taeniasis’’, ‘‘cysticercosis’’,
and ‘‘neurocysticercosis’’. Only one copy of duplicated documents
was kept for analysis. Studies were selected that included original
epidemiological data on NCC frequency. Books and conference
abstracts were excluded because they were unlikely to present
original data or to have sufficient details on methods to judge the
validity of the study. Dissertations, theses, and memoirs were
included. Moreover, due to the under-representation of publica-
tions from Sub-Saharan Africa, three unpublished studies (at that
time) were reviewed in addition to one paper published online in
November 2008 [10]. One unpublished study on the incidence
rate of NCC from Oklahoma was also included since very few
publications reported incidence rates of NCC (Thompson J,
unpublished data).
Another component of this project was to assess the proportion
of sequelae associated with NCC (details reported elsewhere). This
search led to the finding of four additional studies which described
the proportion of NCC among people with epilepsy and seizures
[11–12] and among children with partial seizures [13–14].
Selection
The inclusion and exclusion criteria were defined a priori. In
phase I, all documents retrieved were screened based on title and
abstract. The exclusion criteria for phase I were: 1) wrong agent
(for example, T. saginata); 2) animal data only; 3) no original data
on the frequency of NCC; 4) case series with less than 20
participants; 5) review article without original data; and 6)
editorials or letters to the editors without original data. Documents
without abstracts were included in the next phase. All eligible
Figure 1. Life cycle of Taenia solium cysticercosis (source: CDC-
DPDx). Cysticercosis is an infection of both humans and pigs with the
larval stages of the parasitic cestode, Taenia solium. This infection is
caused by ingestion of eggs shed in the feces of a human tapeworm
carrier (1). Pigs and humans become infected by ingesting eggs or
gravid proglottids (2), (7). Humans are infected either by ingestion of
food contaminated with feces, or by autoinfection. In the latter case, a
human infected with adult T. solium can ingest eggs produced by that
tapeworm, either through fecal contamination or, possibly, from
proglottids carried into the stomach by reverse peristalsis. Once eggs
are ingested, oncospheres hatch in the intestine (3), (8) invade the
intestinal wall, and migrate to striated muscles, as well as the brain,
liver, and other tissues, where they develop into cysticerci (9). In
humans, cysts can cause serious sequellae if they localize in the brain,
resulting in neurocysticercosis. The parasite life cycle is completed,
resulting in human tapeworm infection, when humans ingest under-
cooked pork containing cysticerci (4). Cysts evaginate and attach to the
small intestine by their scolex (5). Adult tapeworms develop, (up to 2 to
7 m in length and produce less than 1000 proglottids, each with
approximately 50,000 eggs) and reside in the small intestine for years
(6). (This life cycle is available online at URL: http://www.dpd.cdc.gov/
dpdx/HTML/Cysticercosis.htm).
doi:10.1371/journal.pntd.0000870.g001
Author Summary
Neurocysticercosis (NCC) is a parasitic infection of the brain
caused by the tapeworm Taenia solium, which infects
humans and pigs. There have been increasing case reports
and epidemiological studies on this disease, but its global
frequency has never been determined, partly due to the
fact that blood tests are not very good for the diagnosis of
NCC. We present here a systematic review of the literature
on the frequency of NCC diagnosed with neuroimaging
worldwide. Overall, 565 articles were retrieved and 290
(51%) selected for further review. Of those, only 26 had
information valid enough to estimate the frequency of
NCC in various populations. Only one study estimated the
prevalence of NCC in the general population. The most
striking finding was that the proportion of NCC among
persons with epilepsy was very consistent and estimated
at 29.6% (95%CI: 23.5%–36.1%) from 12 studies conducted
in Latin America, Sub-Saharan Africa and Southeast Asia. A
reinforcement of the suggested universal guidelines for
the diagnostic process, declaring NCC an international
reportable disease and standardizing procedures for data
collection could improve our understanding of the
frequency of NCC worldwide and hence its global burden.
NCC Frequency: A Systematic Review
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documents after phase I were obtained in full. Each full document
was read and reviewed by at least two investigators and subjected
to the two subsequent phases of review. Phase II and III
corresponded to a qualitative and quantitative appraisal of the
information, respectively. The exclusion criteria for phase II
included all criteria used in phase I in addition to: 1) no neuro-
imaging (CT-scans or MRI) or autopsies used for the diagnosis of
NCC; 2) high potential for selection bias (study of volunteers, study
population obviously more at risk of NCC than the target
population); or 3) all available data from before 1990 or after 2008
(except for sub-Saharan Africa where two studies published in
2009 were included). The data from documents included after
phase II were extracted in phase III.
Data extraction
During phase I, the full reference of each article, the country
where the study was conducted, the decision on inclusion for phase
II, the reason for exclusion (if applicable) and the language of the
document were entered into an Excel spreadsheet (Microsoft
Corp., Redmond, WA). Data were extracted independently by two
authors and a third author checked a random sample of 10% of all
the entries. Any differences were resolved by discussion until
agreement was reached.
The quality assessment (phase II) and data extraction (phase III)
for each document were carried out by two reviewers (except for
Chinese articles) one of whom was a senior researcher (HC or CB).
All documents published in French, Portuguese or Spanish were
reviewed by those who could read those languages (PN and HC).
All documents published in Chinese were reviewed by a Chinese
collaborator (Y-JQ). No articles in German, Romanian or Italian
were identified. In addition, a random sample of 10% of all
English documents was reviewed by all reviewers. Disagreements
were resolved through discussion in a meeting with all the
reviewers. Data were entered into standardized electronic forms of
the data extraction tool which was developed in Access (Microsoft
Corp., Redmond, WA) specifically for this review (available from
the authors on request). Data were collected on the study
characteristics (design, geographic location, period and duration
of the study), participant selection, case definitions, and ascertain-
ment of outcome. For documents that could potentially be
Table 1. Results of search strategies on neurocysticercosis epidemiology published between 1990 and 2008 (June).
Database Link Hits
African Women’s Bibliographic Database http://www.africabib.org/women.html 0
African Journal Online http://www.ajol.info/ 1
Article published after June 2008 1
Articles from other search 4
Bibliothe`que Sante´ Tropicale http://www.santetropicale.com/resume/catalogue.asp 1
Bioline International http://www.bioline.org.br/journals 0
CAB abstracts http://www.cabdirect.org/ 209
China Knowledge Infrastructure (CHKI) http://www.global.cnki.net/ 33
CUIDEN http://www.doc6.es/index/ 0
Ecole Nationale de la Sante´ Publique http://www.bdsp.tm.fr 5
Find Articles http://www.findarticles.com/ 0
GreySource http://www.greynet.org/greysourceindex.html 0
Ind Med http://indmed.nic.in 19
Institute of Tropical Medicine (ITM) in Antwerp
Belgium
http://lib.itg.be:8000/webspirs/start.ws 2
IranMEDEX http://www.iranmedex.com/english/index.asp 1
Japan Science and Technology Information
Aggregator
http://www.jstage.jst.go.jp/browse/ 0
KoreaMed http://www.koreamed.org/SearchBasic.php 0
Me´decine et Pharmacie de l’Universite´, Bamako http://www.keneya.net 0
MetaBase http://infolac.ucol.mx/boletin/14_1/innovaciones1.html 4
OpenMED@NIC http://openmed.nic.in 0
PhD Dissertation 1
PUBMED http://pubmed.org 240
Science Research Portal http://scienceresearch.com/search/index.php 6
The Trials Register of Promoting Health
Interventions (TRoPHI)
http://eppi.ioe.ac.uk/EPPIWeb/home.aspx?Control=Search&SearchDB=trials&page=/hp/ 0
Unpublished data or in press 3
WHO Africa http://indexmedicus.afro.who.int/ 0
WHO Eastern Mediter http://www.emro.who.int/HIS/VHSL 9
WHO South-East Asia http://www.hellis.org 2
WHO Western Pacific http://www.wpro.who.int/information_sources/library_services/wprim.htm 34
doi:10.1371/journal.pntd.0000870.t001
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included in the review but had incomplete or missing data, the
authors were contacted at least twice for clarification and/or
additional information.
Quantitative data synthesis and statistical analysis
The number of documents included in each phase of the
systematic review was first plotted geographically using ArcView
GIS software (ESRI; Redlands, CA). Results from studies
reporting separately the overall prevalence or incidence rate of
NCC in the population are reported for each study.
Measures of frequency: We report the proportion of patients
with NCC in studies where a specific group of patients seeking
care in a hospital or clinic were included. This is obtained by
dividing the number of people with lesions of NCC by the number
of people included in the study (all with neuro-imaging). We report
the proportion of NCC among PWE using the same approach.
The term prevalence is applied to the proportion of people with
lesions of NCC at the CT-scan in studies where the general
population or community residents without epilepsy were
randomly sampled. The 95% Confidence Intervals (95% CI) of
those proportions was estimating using the Clopper-Pearson exact
interval provided in the Stata (StataCorp, College Station, TX)
software. The annual incidence rate of hospitalized cases of NCC
was calculated by dividing the number of cases discharged with an
International Classification of Disease (ICD) code for cysticercosis
by the person-years living in the U.S. state where the study was
conducted (based on census data). The prevalence of NCC-
associated epilepsy was estimated by multiplying the prevalence of
epilepsy by the proportion of NCC conditional on having epilepsy
in community-based studies where both these estimates were
available. This prevalence was estimated using WinBugs 1.4.3
and represents the proportion of people in a community estimated
to have both epilepsy and NCC.
A random-effects model was used to summarize the data on the
proportion of NCC among PWE using R META package
(Version 0.8–2; by Guido Schwarzer in the R-META metagen
function) and the METFOR package (Version 1.3-0; by Wolfgang
Viechtbauer) from R statistical software (R Development Core
Team, www.R-project.org). We used the inverse variance method
[15] to pool the proportion estimates in the random-effect model
and calculate the appropriate 95% Confidence Interval (95% CI)
[16]. Tests of homogeneity were used to determine whether it was
appropriate to combine different proportions across studies, and
the I2 index was used to summarize the total variability in
proportion estimates due to between-study variation [17]. In order
to determine the influence of potential outlying effect-size
estimates, a sensitivity analysis was done by estimating the pooled
prevalence proportion after omitting one study at a time. A mixed-
effects regression model was used to determine whether the study
setting (community-based or clinical-based) significantly influenced
the estimated percentage of NCC among PWE value.
Results
Flow of included studies
The literature search identified 565 documents that could
potentially have original data on the frequency of NCC. The flow
diagram in Figure 2 shows the number of papers identified in each
database and the review process from phase I to phase III. Figure 2
also includes the number and reason for exclusion of documents at
each phase of the review. After the first screening (phase I), 290
publications, including 9 additional studies not originally identi-
fied, were read and critically reviewed. Of the 264 articles
excluded during phase II, the two most common reasons for
exclusion were the lack of frequency data and the lack of neuro-
imaging. Phase III included 26 documents (4.5%) containing
estimates of NCC prevalence proportion or incidence rate
(Table 2).
Geographical distribution of publications on the
prevalence of NCC
As shown in Figures 3a–b, most of the articles identified in the
search were from China, India, Brazil and the United States of
America. The 26 documents that were retained for the
quantitative appraisal (phase III) were from studies conducted in
the WHO regions of Latin America (15), North America (3),
Africa (3) and Asia (5). Figure 3c illustrates the geographic
distribution of the papers that were retained for the quantitative
synthesis.
Study characteristics
Study design, the target populations and the quantity measured
varied greatly across articles (Table 2). Only two studies did not
sample from a target population of people with a specific symptom
or disease [18–19]. Most studies reported the proportion of people
with NCC among symptomatic target populations. Two studies
from the United States of America reported the incidence rate of
NCC based on hospital discharge data ([20], Thompson J,
unpublished data), and four studies reported the proportion of
NCC among people who were autopsied after death for any
reason [7,21–23]. In seven community-based studies, NCC was
assessed among PWE or people with seizure disorders ([8,24–28],
Carabin et al, unpublished data). In another five studies, NCC was
assessed among PWE attending a health clinic [10–12,29–30]. In
addition, in three studies, NCC was specifically measured among
children with partial seizures [13–14,31].
Prevalence of NCC in the general population
Only one study reported the prevalence of NCC in a random
sample of the general population (Table 3). In this Mexican study,
154 residents were sampled at random to receive a CT-scan of the
brain [19]. The prevalence of NCC was estimated to be 9.1%
(95% CI: 5.1%–14.8%). None of the sampled subjects had
clinically apparent manifestations of NCC. The prevalence of
NCC was considerably higher among children (aged 0–19 years
old) with an estimated prevalence of 13.2% (95% CI: 7.0%–
21.9%) than among adults (20–54 years old) with an estimated
prevalence of 3.2% (95% CI: 0.4%–11.0%).
Prevalence of NCC among people without epilepsy and
epileptic seizures
Two studies were conducted among patients without epilepsy and
epileptic seizures, both part of a larger door-to-door survey to
identify people with epilepsy conducted in Ecuador. In the first
study, lesions suggestive of NCC at CT were found in 17 out of 118
randomly selected people without epilepsy [8], for a percentage of
14.4% (95%CI: 8.5%–21.2%). In the second study, NCC lesions
were identified among a matched age-gender sample of 19 people
without epilepsy (matched to those with epilepsy), for a percentage
of 5.2% (95%CI: 0.1%–26.0%) [24]. No details on the age
distribution or types of lesions found were provided in those articles.
Proportion of NCC among community residents
seropositive and seronegative to the presence of
antibodies to T. solium
The proportion of NCC in seropositive and seronegative
community residents was estimated in two studies [18,27]. In
NCC Frequency: A Systematic Review
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Figure 2. Flowchart describing the number of papers remaining at different phases of the study.
doi:10.1371/journal.pntd.0000870.g002
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Honduras, 480 people aged 2 years and older from Salama
county, provided a blood sample to estimate the seroprevalence of
cysticercosis using a Western Blot (EITB) [18]. A total of 80 people
tested positive to the EITB, of whom 74 accepted to receive a CT-
scan of the brain. An age-gender-village matched sample of 74
sero-negative people also received a CT-scan of the brain. In the
second study, 825 out of 913 residents of seven villages of the
district of Matapalo in Peru provided a blood sample for EITB
testing. A random sample of 53 of 60 people testing positive and
58 of 60 people testing negative to EITB without epilepsy accepted
to have a CT-scan of the brain [27]. The percentage of NCC was
23.0% (95% CI: 14.0%–34.2%) and 34.0% (95% CI: 21.5%–
48.3%) among seropositive participants, and 18.9% (95% CI:
10.7%–29.7%) and 13.8% (95% CI: 6.1%–25.4%) among
seronegative patients in Honduras and Peru, respectively. Age-
stratified prevalence of NCC results was not reported. It is
important to note that none of those groups represents the general
population of those villages.
Estimates of annual incidence rate of hospitalized NCC
cases
Two studies, both using data from discharge diagnosis of
patients hospitalized in the United States of America, reported
estimates of the incidence rate of hospitalized NCC per 100,000
person-years (Table 2). In Oregon and Oklahoma, the incidence
rates were estimated at 1.50 per 100,000 person-years and 0.29
per 100,000 person-years, respectively ([20], Thompson, unpub-
lished data).
Proportion of NCC in selected groups of clinical patients
As expected, the proportion of NCC was extremely variable
among studies with different source and target populations
(Table 3). In Peru, the percentage of NCC in children with
partial seizures was 52.0% (95% CI: 38.5%–65.2%) [31]. This
estimate was considerably lower in two studies conducted among
children with partial seizures in India (Table 2) [13–14]. The latter
two studies did not consider solitary calcified cysts as NCC lesions.
In a study conducted among a group of patients attending two
imaging diagnostic centers in Brazil, the percentage of NCC was
estimated at 0.20% (95% CI: 0.15%–0.24%) [32].
We found only one study from a developed country (United
States) reporting the percentage of NCC among people with
seizures attending emergency rooms [33]. In that study, the overall
prevalence of NCC was 2.1% (95% CI: 1.5%–2.9%), but was
9.1% (95% CI: 6.2%–12.8%) among Hispanics.
Proportion of NCC among autopsied patients
Four studies reported the proportion of NCC among people
who were autopsied [7,21–23]. The percentages were similar
across the four studies, varying from 1.5% to 2.6%, with three of
the four studies conducted in the same area of Brazil (Table 3).
Table 3. Frequency* of NCC (95% CI) identified in the systematic review.
Country, year(s) of study Reference Measure of frequency % NCC 95% CI
Brazil, 1970–03 [23] Percentage of NCC among autopsies of adults 2.4 1.8–3.0
Brazil, 1974–97 [22] Percentage of NCC among autopsies of adults 2.6 1.8–3.4
Brazil, 1992–97 [7] Percentage of NCC among autopsies of adults 1.5 1.0–2.0
Mexico, 1993–96 [21] Percentage of NCC among autopsies of adults 1.9 1.2–2.8
India, 2000–03 [42] Percentage of NCC among people with JE* 19.4 14.6–24.8
Brazil, 1992– 02 [32] Percentage of NCC among people with a brain CT-scan 0.2 0.15–0.24
Peru, 1998–99 [31] Percentage of children (ages 2–14) with partial seizures 52.0 38.5–65.2
India, 1995–99 [14] Percentage of children (ages 1–12) with partial motor seizures 2.01 0.4–5.7
India, 1992–93 [13] Percentage of children (ages 0–15) with simple partial seizures 10.11 6.3–15.2
USA, 1996–98 [33] Percentage of people with seizures seen in emergency rooms 2.1 1.5–2.9
Honduras, 1995 [18] Prevalence among people EITB positive 23.0 14.0–34.2
Honduras, 1995 [18] Prevalence among people EITB negative age-sex-village matched to EITB+ 18.9 10.7–29.7
Peru, 1999–00 [27] Prevalence among people EITB positive and without epilepsy 34.0 21.5–48.3
Peru, 1999–88 [27] Prevalence among a SRS** of people EITB negative and without epilepsy 13.8 6.1–25.4
Mexico, 1999–00 [19] Prevalence among a SRS** of people in the community 9.1 5.1–14.8
Ecuador, 1994 [8] Percentage among a SRS** from people without epilepsy in a community 14.4 8.5–21.2
Ecuador, 2003 [35] Percentage among a age-gender matched (to epilepsy cases) sample of
people without epilepsy in a community
5.2 0.1–26.0
USA, 1995–00 [20] Incidence rate of inpatients with NCC (/105 person-years) 1.5
USA, 2002–05 Thompson,
unpublished
Incidence rate of inpatients with NCC (/105 person-years) 0.29
*JE: Japanese encephalitis;
**SRS: Simple random sample;
1NCC excluded patient with solitary cyst or granuloma in the brain.
doi:10.1371/journal.pntd.0000870.t003
Figure 3. Distribution of documents identified during a systematic search of the literature from 1990 to 2008 on the frequency of
neurocysticercosis which were included in the three phases of the review. a) Phase I (n = 565), b) Phase II (n = 290) and c) Phase III (n = 26).
doi:10.1371/journal.pntd.0000870.g003
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Prevalence of NCC-associated epilepsy in community-
based studies
The estimated prevalence of people with NCC-associated
epilepsy in community-based studies ranged from 0.1% in India
[28] to 1.3% in a study of three rural communities in Burkina Faso
(Carabin, unpublished data) (Table 4). Such estimates could not be
combined because the proportion of NCC was never obtained
from all PWE in the population.
Proportion of NCC among people with epilepsy
The proportion of NCC among PWE was remarkably
homogeneous across studies conducted in children and adults
(Figure 4). The lowest estimated percentage was from a study
conducted in several urban clinics in Colombia, with an estimated
13.9% NCC among PWE (95% CI: 11.1%–17.1%) [29].
Interestingly, all patients with single calcifications in that study
were considered as negative for NCC. The pooled estimate across
12 studies from the random-effects model for the percentage of
NCC among PWE of all ages was 29.0% (95% CI: 22.9%–35.5%).
The I2 statistic indicated that 92.5% (95% CI: 88.1%–94.6%) of
the total variability in the percentage values was due to between-
study variation. No study had a significant impact on the result
and the between-study variability was not explained by a single
study.
We ran the model excluding the study from Peru where some
single seizures cases were included [27] and only including patients
with epilepsy or recurring acute symptomatic seizures from one of
the India studies [12]. The resulting pooled estimate is 27.6%
(95%CI: 22.8%–32.6%), which is very close to the previous
estimate.
We also ran random-effect models stratified by the target
population (clinical vs community). The estimates were 31.7%
(95% CI: 25.6%–38.2%) for community-based and 25.4%
(95%CI: 16.3%–35.7%) for clinical-based studies. A mixed-effects
regression model was used to determine whether the study setting
(community-based or clinical-based) significantly influenced the
percentage value. The estimated percentage among clinic-based
studies is expected to be 5.9% lower (absolute difference) than that
for community-based studies (95% CI: 17.2% lower to 5.5%
higher), which is not statistically significant (p = 0.31).
Only five of the 12 studies had sufficient information to obtain
estimates stratified by two broad and consistent age groups. In
patients less than 20 years of age, the percentage of NCC among
PWE ranged from 11.1% (95% CI: 2.4%–29.2%) in a community-
based study in Burkina Faso (Carabin, unpublished data) to 45.2%
(95% CI: 27.3%–64.0%) in the Eastern Cape Province of South
Africa [30], with an overall estimate of 24.8% (95% CI: 18.2%–
32.2%) (Figure 5a). The I2 statistic suggested that 43.1% (95%: CI
0%–76.1%) of the total variability in the values was due to
between-study variation. In the analysis of adults aged 20 to 54
years, the estimate of the percentage of NCC among PWE was
more variable, ranging from 14.2% (95% CI: 8.6%–21.5%) in an
outpatient clinic in Tanzania [10] to 50.0% (95% CI: 28.2%–
71.8%) in a community in Peru [27], with an overall estimate of
28.3% (95% CI: 19.9%–37.5%) (Figure 5b). I2, the percentage of
total variation across studies due to between-study heterogeneity,
was 74.8% (95% CI: 46.6%–88.2%).
Discussion
This is the first study to systematically collect data on the
frequency of NCC worldwide Our results demonstrate that there is
not sufficient evidence at this time to estimate the prevalence of
NCC globally. However, our study is the first meta-analysis to
summarize the proportion of NCC among PWE, and suggest that
nearly one-third of PWE living in endemic communities show
lesions of NCC in their brain. Our study is particularly
comprehensive because it used 25 different databases to identify
published information and included documents published in four
different languages.
Methodological issues
After a systematic review, only studies that are likely to be valid
and are similar enough in their methods and definitions should be
reported [34]. Only 4.5% of all publications identified were
considered valid enough to be included in the systematic review.
However, only studies reporting on the proportion of NCC among
PWE were similar enough to be combined in a pooled estimate.
The second most common reason for exclusion of documents,
after an absence of measurement of NCC frequency, was the lack
of neuro-imaging for the diagnosis of NCC. Underdeveloped
countries where sanitation and proper pig management methods
are lacking are often endemic for T. solium infections [8,35]. These
same countries are those where imaging facilities are scarce [28];
this especially applies to Sub-Saharan Africa [36]. The absence of
appropriate diagnostic technologies leads to an unequal distribu-
tion of studies included in this systematic review. Indeed, there are
few articles from Africa, the Western Pacific, the Eastern part of
Europe and Asia, with the exception of India and China. The
small number of studies from the Middle East and parts of Africa is
Table 4. Prevalence (%) of NCC-associated epilepsy and 95% Bayesian Credible Interval (95% BCI) in community-based studies.
Country, year Reference
Number of people
with NCC (number
with CT-scans)
Number of
people with
Epilepsy
Number of
people screened
for the presence
of epilepsy
% NCC-associated
epilepsy in the study
population (95%BCI)
Bolivia, 1994 [25] 29 (105) 124 9955 0.35 (0.24–0.49)
Ecuador, 1994 [8]* 14 (26) 31 2723 0.62 (0.36–0.97)
Ecuador, 2003 [24] 5 (19) 23 2415 0.27 (0.11–0.54)
Honduras, 1997 [26]* 33 (90) 100 6473 0.57 (0.40–0.78)
Burkina Faso, 2007 Carabin; unpublished 17 (68) 39 888 1.32 (0.81–2.05)
Urban India, 2003 [28]* 35 (101) 116 38105 0.11 (0.07–0.15)
Rural India, 2003 [28]* 11 (61) 78 12512 0.12 (0.06–0.20)
*These studies only included patients with active epilepsy (defined by at least one epileptic seizure in the past 5 years).
doi:10.1371/journal.pntd.0000870.t004
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not surprising since pig rearing and pork consumption are rare in
those areas. . Yet, a small number of studies have reported NCC
cases in Islamic or Jewish communities [37] and it would be
commendable to conduct more studies of NCC in those
communities. Infection usually occurs when individuals from
endemic areas are taeniasis carriers [38]. Restriction to studies
using neuroimaging was based on the internationally accepted
descriptions of lesions of NCC which requires the use of imaging
for the diagnosis of this disease [39].
The third most common reason for exclusion of a study was the
use of flawed methodology. Studies were excluded that did not
mention when and where they were conducted as were primary
studies with a high potential of selection bias, since the strength of
a systematic review depends on the quality of the primary studies
Figure 4. Forest plots of the proportion of NCC (95% CI) in people with epilepsy from 12 studies reporting from cases in all age
groups. *Indicates studies among people with epilepsy and seizures. ** Indicates studies among people with active epilepsy only.
doi:10.1371/journal.pntd.0000870.g004
Figure 5. Forest plots of the proportion of NCC (95% CI) among people with epilepsy in children and adults. a) people aged between 0
and 19 years old and b) aged 20 years old or more. *Indicates studies among people with epilepsy and seizures. ** Indicates studies among people
with active epilepsy only.
doi:10.1371/journal.pntd.0000870.g005
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that are included [40]. Methodologically poor studies may bias the
conclusions and produce incorrect overall estimates when
quantitative methods are used [41].
The proportion of NCC in specific populations
Target and study populations were very different across the
documents we analyzed. For example, studies were conducted on
patients with Japanese encephalitis (JE) [42], a simple random
sample of people living in a community in Mexico [19], patients
attending imaging diagnostic centers [11,32] and children with
partial seizures [13–14,31]. The frequency of NCC across these
populations varied widely and the heterogeneity between studies
hindered the calculation of an overall estimate. Only studies
conducted among PWE were homogeneous enough to warrant the
use of a meta-analysis.
The only cross-sectional study among a random sample of the
population found a prevalence of NCC lesions, all calcified, of
9.1% [19]. This prevalence is similar to what was found in one
study conducted in Ecuador where people without epilepsy and
epileptic seizures were selected at random [8]. None of those
studies reported on the presence of other possible past or present
neurological manifestations of NCC. Therefore, even though it is
possible that those participants were truly asymptomatic, it is
impossible to know with certainly in the absence of a full
neurological examination and anamnesis.
In another study, people who were sero-positive to the EITB
and an age-sex-village matched sample of sero-negative people
underwent a CT-scan of the brain [18]. Even though this study is
interesting in showing that the prevalence of NCC was very similar
in the two groups, suggesting the poor performance of the EITB to
detect NCC in community-based studies conducted in endemic
areas, it cannot be used to estimate the prevalence of NCC. This is
because people who are sero-positive (and their match controls)
may represent people who are more exposed to the larval stages of
T. solium in their community. Given that the incubation of NCC is
unknown, those participants testing negative to the EITB may
have been exposed a long time ago but have seen their immunity
wane with time. Those cases may also have never developed
antibodies to the brain infection. Such studies are unlikely to be
repeated in the future. Due to potential adverse effects of the
contrast materials used for CT or MRI, it is usually considered
unethical to perform neuro-imaging in apparently healthy
individuals. This limits our ability to truly measure the burden
of NCC as some people may be asymptomatic for extended
periods of time [43]. The study among participants seropositive
and seronegative to EITB from Peru is even more difficult to
interpret since it was conducted only among those without epilepsy
[27].
We identified four studies conducted in autopsied patients from
large hospitals in Brazil and Mexico [7,21–23]. These results were
very similar, but three of the four studies were conducted in the
same province of Brazil, thus representing the same population. In
addition, an extrapolation of those results to the general
population is impossible since people who are autopsied are likely
to systematically differ from the general population.
The prevalence of NCC-associated epilepsy in
community-based studies
The prevalence of people with NCC-associated epilepsy in
community-based studies varied considerably. This prevalence is
the product of the prevalence of PWE in the community and the
proportion of NCC among PWE. Since the prevalence of NCC
among PWE tends to be similar across studies (about one-third),
the prevalence of epilepsy in communities is the parameter that
contributes the most to the observed variability across communi-
ties. There are diverse, competing etiologies for epilepsy across
countries and in addition to NCC include malaria, paragonomia-
sis, toxocariasis, and other parasites of the brain [5], a plethora of
metabolic disorders, traumatic brain injuries as well as febrile
seizures during childhood [44]. The inconsistency in prevalence
estimates can also be explained by the fact that the definition of
epilepsy and of active epilepsy varied from study to study. Some
authors used a cutoff of one year of unprovoked seizures whereas
others used three or five years to define active epilepsy.
The proportion of NCC among PWE
The results from our meta-analysis show that epilepsy is
consistently associated with NCC in over one quarter of patients
residing in endemic regions. This result was very robust, regardless
of the type of epilepsy, if single epileptic seizures were included or
not, and where and among whom the study was conducted. In an
older study of 100 consecutive patients with epilepsy, Medina et al.
found a prevalence of 50% for NCC [45]. Another study in South
Africa conducted on 578 PWE, calculated a proportion with NCC
of 28% [46], which is very close to the average in the articles
reviewed in this meta-analysis. These estimates confirm the
importance of NCC infection in the etiology of epilepsy in
developing countries [45] and suggest that NCC may be
associated with a very large burden in cysticercosis endemic areas
where epilepsy is prevalent.
It is difficult to determine if our finding of the proportion of
NCC lesions among PWE is an over or underestimate of the truth.
First, epidemiological studies are generally conducted in areas
where the infection is expected to be common. Second, as describe
in the Mexican study [19], some proportion of the population have
NCC lesions in the brain that are not manifesting (at least at the
time of the study). These two factors would support an
overestimation of the proportion of epilepsy that could be
attributable to NCC in endemic communities. However, in a
pilot study conducted in three communities in Burkina Faso, one
of the communities selected had very few pigs and most of the
residents were Muslim. There were no NCC cases among PWE in
that community, which was located only about 10 km from
another community where about 45% of PWE had lesions of
NCC (Carabin, unpublished results). The combined proportion of
NCC among PWE was 29%. This suggests that our estimate may
be accurate if the selected study communities represented rural
areas of a country. However, if communities with clusters of NCC
were specifically selected, then our results would be an
overestimation of the country-wide reality.
In three of the studies, single calcifications and/or single
enhancing lesions were not considered as lesions compatible with
NCC. This goes against the lesions described in Del Brutto et al.
[39] which consider single, calcified lesions as a minor criterion,
and does not consider the fact that some single calcified lesions
may very well be NCC if combined with a positive result to EITB
[47]. This could lead to an underestimate of the true prevalence.
Even though not all single calcified lesions of the brain will be
NCC, we assessed what impact the inclusion of all of those lesions
as NCC would have had on the results. In the two India studies,
the percentage of NCC among children with partial seizures
would have increased from 10.1% to 38.1% in one study [14] and
from 2.0% to 12.0% in the other study [13]. In the study by
Palacio et al. in Colombia [29], the estimate of NCC among PWE
would have increased from 13.9% to 22.7%. We conducted a
sensitivity analysis assuming that those solitary cysts were NCC in
the Palacio study. This analysis yielded a pooled estimate of NCC
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among PWE of 30.3% (95% CI: 25.3%–35.5%), which is very
similar to the previous estimate.
The proportion of NCC among children with epilepsy and
partial seizures
It is generally believed that NCC is a cause of late-onset
epilepsy. Our meta-analysis contradicts this belief by obtaining
very similar pooled estimates of the proportion of NCC among
PWE in adults (aged 20 years old or more) and children (aged less
than 20 years old). The proportion of NCC among children with
partial seizures varied considerably. However, it does support the
fact that children are affected by NCC.
Limitations of the study
Our study has some limitations with regards to missing data,
potential biases, and misclassification. Although a very broad
search in seven different languages was conducted, relevant papers
may have been overlooked. This situation may have the
consequence of introducing a bias in the synthesis we were aiming
to produce. Another potential bias may be publication bias, as we
mainly considered published papers [48]. Apart from the specific
region of Sub-Saharan Africa, we were unable to locate
unpublished studies from other areas. To our knowledge, there
have not been any published studies of NCC using neuro-imaging
conducted in Viet-Nam, Cambodia, Laos or the Philippines
(Willingham, personal communication, May 2009).
Another important limitation is that the ascertainment of NCC
cases remains a problem. Although CT and MRI are considered
the best tools to diagnose NCC, they can miss early stages of the
larvae infestation in the brain [49]. The definitive diagnosis of
NCC has to be made by a set of methods including neuro-imaging
procedures, histological techniques and immunological investiga-
tions, because the use of any single method may provide flawed
diagnoses [50]. As mentioned earlier, many neuro-imaging lesions
are not pathognomonic of NCC [51]. Unequivocal diagnosis can
only be achieved by absolute recognition of a scolex on neuro-
imaging, or by biopsy or autopsy [39,49]. However, invasive
procedures are rarely routinely performed for diagnostic purposes
[49]. Hence, our findings, which rely on a CT-scan diagnosis, may
over- or underestimate the actual frequency of NCC. Whether it is
an over-estimate due to counting lesions that are not NCC
depends on how much of NCC does manifest as epileptic seizures.
Indeed, since all our studies are cross-sectional in nature, it is
impossible to determine if the NCC lesion is indeed the cause of
the epileptic seizures. This problem could be exacerbated by the
fact that radiologists may have had a wide variance in CT
interpretation, especially for small, calcified lesions [51].
A further limitation of this systematic review is that most
published studies have been based on small sample sizes. Gender
and age-specific data were often not available and, when reported,
the age groups were not consistent. Most of the authors we
contacted for additional information did not answer our
correspondence. Hence, we could only report the prevalence
estimates from a sub-sample of the studies and in two very broad
age groups. Interestingly, we noticed that the prevalence of NCC
among PWE in children aged less than 20 was much higher in
South Africa. This supports prior reports suggesting that NCC
may be more common in children in South Africa than elsewhere
[52]. Gender-specific estimates could not be calculated, and we
could not verify whether females are more affected by NCC, as has
been previously hypothesized [50].
Finally, all the available literature is based on cross-sectional
studies in communities or clinics that selected PWE and offered
them a CT-scan of the brain. It is impossible to determine the
temporality of the link between NCC and epilepsy in such study
design. Unfortunately, a cohort study of people developing brain
lesions of NCC which follows them to see if they develop epilepsy
is not ethically feasible. Among the literature reviewed, one was a
prevalence case-control study and reported a prevalence odds ratio
of 6.9 between NCC and epilepsy [8].
This systematic review has shown several challenges for the
assessment of NCC’s global burden. One way to improve the
assessment of the global burden of NCC would be to encourage
and enforce the use of a standard diagnosis for NCC, such as that
developed by Del Brutto et al. [39]. This may require the provision
of adequate diagnostic tools and expertise to all endemic countries.
A second step would be to follow the proposal of some authors to
declare NCC an international reportable disease [53]. This
proposal was reviewed and rejected by the World Health
Assembly in 2003 because it was felt that only diseases which
can lead to large-scale international outbreaks should be included
in the list of internationally notifiable diseases [54]. However,
countries were encouraged to add this disease to their national list
of notifiable diseases. Compulsory notification would have the
benefit of providing accurate quantification of NCC prevalence in
endemic areas. In 1992, the municipality of Ribeira˜o Preto in
Brazil, decided to make NCC a reportable disease in that region
[7]. With the standardization of NCC diagnostic criteria and
compulsory notification, the global burden of NCC would be
easier to establish. A future systematic review of published and
unpublished documents, extended to all relevant documents
reporting NCC cases, will help capture more complete data. In
order to standardize how NCC is reported in articles, we also
propose to share the AccessTM data extraction tools that were
developed for this review. Data collected in the same way will be
easier to combine. Collaborative data would improve the focus
and decision-making regarding preventive measures for a disease
that has severe complications.
Despite these challenges, this study found that approximately
one-third of people with epilepsy living in regions endemic for T.
solium were associated with NCC. While this estimate may be
biased due to measurement error, its robustness across populations
and studies suggest that it is likely to be accurate. The number of
DALYs lost due to epilepsy worldwide was estimated to be
6,223,000, with slightly higher values for males (3,301,000) than
for females (2,922,000) [55]. Many risk factors for epilepsy are
linked with a lower level of economic development; thus, the
burden is highest in South Asia, followed by Sub-Saharan Africa
[54]. In India, the DALY for epilepsy estimated in 2002 was 1539
[56].
Given the very robust estimate of the proportion of people with
NCC lesions among PWE and, in some cases people with epileptic
seizures, it may be possible to use the range of the percentage of
NCC among PWE to estimate the number of NCC-associated
epilepsy cases in endemic areas. To achieve this goal, we will need
to obtain information on the prevalence of epilepsy in areas that
are endemic for cysticercosis, that is, those countries were
sanitation is poor, pork consumption occurs, and pigs have access
to human feces. In the literature that we have reviewed, we have
not come across publications suggesting that NCC is not endemic
in areas where these three conditions are met. By multiplying the
range of prevalence of epilepsy by the range of the proportion of
NCC among PWE in each endemic area, we would obtain a range
of values for the prevalence of NCC-associated epilepsy. Since
epilepsy has been reported as the most common manifestation of
NCC, such estimates will probably capture the majority of NCC-
associated burden. This information will ultimately lead to the
estimation of prevalence DALYs associated with NCC.
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